XFOR (X4 Pharmaceuticals) Insider Ownership: 9.77 % (As of Jul. 13, 2026)


XFOR X4 Pharmaceuticals Inc XFOR
26 GF Score
Price $4.05
! 7 Warning Signs
View Full Analysis

What is X4 Pharmaceuticals Insider Ownership?

Author: Vera Yuan Vera Yuan Reviewed by: Charlie Tian Charlie Tian

X4 Pharmaceuticals XFOR -8.06% 26 Insider Ownership is 9.77 % as of Jul. 13, 2026. GuruFocus rates XFOR with a GF Score™ of 26/100. The stock has 7 warning signs investors should review.

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, X4 Pharmaceuticals's insider ownership is 9.77%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, X4 Pharmaceuticals's Institutional Ownership is 108.04%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, X4 Pharmaceuticals's Float Percentage Of Total Shares Outstanding is 99.79%.

X4 Pharmaceuticals Insider Ownership Historical Data

* Premium members only.

The historical data trend for X4 Pharmaceuticals's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

X4 Pharmaceuticals Insider Ownership Chart

X4 Pharmaceuticals Historical Data

The historical data trend for X4 Pharmaceuticals can be seen below:

2025-02-28 2025-03-31 2025-08-31 2025-09-30 2025-10-31 2025-11-30 2026-01-31 2026-02-28 2026-05-31 2026-06-30
Insider Ownership 5.54 5.44 39.30 39.30 11.83 11.83 11.83 11.83 9.78 9.77
XFOR
26GF Score
X4 Pharmaceuticals Inc XFOR
Insider Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

X4 Pharmaceuticals Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.

Frequently Asked Questions Learn more about Insider Ownership →
What does a Insider Ownership of 9.77 % mean?
X4 Pharmaceuticals (XFOR) has a Insider Ownership of 9.77 % as of Jul. 13, 2026. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on X4 Pharmaceuticals and its competitors.
Is X4 Pharmaceuticals' Insider Ownership too high?
X4 Pharmaceuticals' current Insider Ownership is 9.77 %. Overall, X4 Pharmaceuticals has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does X4 Pharmaceuticals' Insider Ownership compare to CMPX and LRMR?
X4 Pharmaceuticals' Insider Ownership of 9.77 % can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Insider Ownership for a Biotechnology company?
A good Insider Ownership depends on the Biotechnology industry context. However, Insider Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Insider Ownership mean?
A high Insider Ownership can signal that a stock is expensive relative to its fundamentals. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on X4 Pharmaceuticals and its competitors. X4 Pharmaceuticals's current Insider Ownership is 9.77 %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is X4 Pharmaceuticals stock overvalued right now?
X4 Pharmaceuticals (XFOR) has a current Insider Ownership of 9.77 %. The current Insider Ownership is 9.77 %. X4 Pharmaceuticals' overall GF Score™ is 26/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Insider Ownership calculated?
Insider Ownership is calculated from a company's financial statements. For X4 Pharmaceuticals (XFOR), the current Insider Ownership is 9.77 % as of Jul. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

X4 Pharmaceuticals Business Description

Address 61 North Beacon Street, 4th Floor, Boston, MA, USA, 02134
X4 Pharmaceuticals Inc is a biopharmaceutical company developing and commercializing novel therapeutics for the treatment of rare hematology diseases. The Company's clinical candidate is mavorixafor, a small molecule antagonist of the chemokine receptor CXCR4 that is being developed as an oral, once-daily therapy. It can increase the mobilization of mature, functional white blood cells from the bone marrow into the bloodstream. It also has two pre-clinical candidates X4P-003 and X4P-002 which are CXCR4 antagonists with different properties.
26GF Score

Get the complete analysis for XFOR

Insider Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.05
Price